Stacie Dodgson, PhD
@staciedodgson.bsky.social
Chief Scientific Strategist, Gladstone-UCSF Institute of Genomic Immunology.
Former Cell editor.
Genetics, genomics, immunology, oceanology, mixology, always collecting new -ologies.
Former Cell editor.
Genetics, genomics, immunology, oceanology, mixology, always collecting new -ologies.
Reposted by Stacie Dodgson, PhD
Executive wants to frame the NIH indirects cut as $4B in savings.
But given that NIH returns $2.5 on every $1 investment, this would actually cost US economy a net $6 BILLION (per year!). Not to mention the human costs of wrecking education and research sectors and the communities they serve.
But given that NIH returns $2.5 on every $1 investment, this would actually cost US economy a net $6 BILLION (per year!). Not to mention the human costs of wrecking education and research sectors and the communities they serve.
Direct Economic Contributions
NIH directly supports the economy through investments in research institutions and job formation.
www.nih.gov
February 8, 2025 at 3:08 AM
Executive wants to frame the NIH indirects cut as $4B in savings.
But given that NIH returns $2.5 on every $1 investment, this would actually cost US economy a net $6 BILLION (per year!). Not to mention the human costs of wrecking education and research sectors and the communities they serve.
But given that NIH returns $2.5 on every $1 investment, this would actually cost US economy a net $6 BILLION (per year!). Not to mention the human costs of wrecking education and research sectors and the communities they serve.
Reposted by Stacie Dodgson, PhD
A very simple script. Feel free to adjust for your needs.
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
February 8, 2025 at 2:02 PM
A very simple script. Feel free to adjust for your needs.
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
Reposted by Stacie Dodgson, PhD
This is a list of blockbuster drugs in 2024. Guess how many can trace their origins to NIH funded research?
All of them.
All of them.
February 8, 2025 at 4:09 AM
This is a list of blockbuster drugs in 2024. Guess how many can trace their origins to NIH funded research?
All of them.
All of them.
Reposted by Stacie Dodgson, PhD
Vaccines have saved + continue to save millions of lives from infectious diseases. It is normal to have questions about how they work & what makes a successful vaccine. In that spirit here are 3 excellent articles from people worth listening to - pls share:
February 1, 2025 at 6:17 PM
Vaccines have saved + continue to save millions of lives from infectious diseases. It is normal to have questions about how they work & what makes a successful vaccine. In that spirit here are 3 excellent articles from people worth listening to - pls share:
Reposted by Stacie Dodgson, PhD
Vaccines and immunization fact sheets you can't find on CDC website anymore are archived at the link below. May be helpful to bookmark this for future reference.
www.immunize.org/vaccines/vis...
www.immunize.org/vaccines/vis...
Vaccine Information Statements (VISs) Overview | Immunize.org| Immunize.org
Find materials on legal requirements to give VISs to patients before vaccinating.
www.immunize.org
February 1, 2025 at 2:37 PM
Vaccines and immunization fact sheets you can't find on CDC website anymore are archived at the link below. May be helpful to bookmark this for future reference.
www.immunize.org/vaccines/vis...
www.immunize.org/vaccines/vis...
Karin Pelka is co-organizing a Single Cell Biology To Tissue Ecosystems @keystonesymposia.bsky.social conference, May 11-14 in Whistler, abstract deadline February 11. It’s immunology-heavy, but covers a few disease areas and will be joint with the Organoid Engineering Keystone. Take a look 👇
Submit your abstracts or scholarship applications by Feb. 11 (11:59pm MST) to present alongside experts like Matthew F. Krummel & Gordana V. Vunjak-Novakovic. See you in May! keysym.us/KSSingleCell25
#KSSingleCell25 #singlecellbiology #singlecellanalysis #cellatlas #tissueatlas #spatialomics
#KSSingleCell25 #singlecellbiology #singlecellanalysis #cellatlas #tissueatlas #spatialomics
January 30, 2025 at 2:46 PM
Karin Pelka is co-organizing a Single Cell Biology To Tissue Ecosystems @keystonesymposia.bsky.social conference, May 11-14 in Whistler, abstract deadline February 11. It’s immunology-heavy, but covers a few disease areas and will be joint with the Organoid Engineering Keystone. Take a look 👇
Reposted by Stacie Dodgson, PhD
Leading Edge is celebrating a milestone: 100 (actually 102!) new assistant professors!!! 🎉🥳🎊
Learn more about them:
www.leadingedgesymposium.org/fellows/
Applications are now open for the 2025 Leading Edge cohort! (Deadline Feb 3).
You do NOT need to be ready for the job market to apply.
Learn more about them:
www.leadingedgesymposium.org/fellows/
Applications are now open for the 2025 Leading Edge cohort! (Deadline Feb 3).
You do NOT need to be ready for the job market to apply.
January 6, 2025 at 5:56 PM
Leading Edge is celebrating a milestone: 100 (actually 102!) new assistant professors!!! 🎉🥳🎊
Learn more about them:
www.leadingedgesymposium.org/fellows/
Applications are now open for the 2025 Leading Edge cohort! (Deadline Feb 3).
You do NOT need to be ready for the job market to apply.
Learn more about them:
www.leadingedgesymposium.org/fellows/
Applications are now open for the 2025 Leading Edge cohort! (Deadline Feb 3).
You do NOT need to be ready for the job market to apply.
Reposted by Stacie Dodgson, PhD
Seeking pioneering scientists in immunology, neuroscience, and machine learning! Join Arc Institute as a Core Investigator + Stanford Bioengineering as Associate/Full Professor. Full lab funding and cutting-edge facilities in Palo Alto. Apply by Jan 15 for full consideration: shorturl.at/CuH1K
Associate or Full Professor Rank Search to join the Arc Institute as a Core Investigator and the Stanford Department of Bioengineering | Arc Institute
Arc Institute is a independent nonprofit research organization headquartered in Palo Alto, California.
arcinstitute.org
January 8, 2025 at 11:44 PM
Seeking pioneering scientists in immunology, neuroscience, and machine learning! Join Arc Institute as a Core Investigator + Stanford Bioengineering as Associate/Full Professor. Full lab funding and cutting-edge facilities in Palo Alto. Apply by Jan 15 for full consideration: shorturl.at/CuH1K
Reposted by Stacie Dodgson, PhD
For me it is "Naturally occurring T cell mutations enhance engineered T cell therapies"
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
Naturally occurring T cell mutations enhance engineered T cell therapies - Nature
A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
www.nature.com
December 27, 2024 at 3:21 PM
For me it is "Naturally occurring T cell mutations enhance engineered T cell therapies"
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.